Conclusions: These findings identify a significant discrepancy between the billing of tobacco cessation services and the ...
Achieve Life Sciences, Inc. announced promising results from its ORCA-3 clinical trial of cytisinicline for smoking cessation, published in JAMA Internal Medicine. This Phase 3 study involved 792 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results